This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Journalology/ Peer Review/ Authorship  • Adverse Effects  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

In the past several years, I can think of no single clinical issue that has moved faster than the COX-2 inhibitor story. Even the daily news media have found it difficult to keep the reports orderly and credible. I am confident that most readers of the medical literature appreciate that it is difficult, if not impossible, to keep medical readers informed of the latest science in a fast-moving field, not to mention the notion that we might also try to keep our readers up-to-date with the daily news.

The APC was first fully reported in an early release article in the New England Journal of Medicine on February 15, 2005.¹ The ARCHIVES editorial by Solomon and Avorn² was accepted in December 2004 and published on January 24, 2005. As stated in my Editor’s Note in the article by Sowers et al in that same issue of the . . . [Full Text of this Article]

Philip Greenland, MD, Editor

RELATED ARTICLES

Inconsistency in the Editorial Process in Archives of Internal Medicine?
Nina H. Bjarnason
Arch Intern Med. 2005;165(12):1439-1440.
EXTRACT | FULL TEXT  

Inconsistency in the Editorial Process in Archives of Internal Medicine?—Reply
Daniel H. Solomon and Jerry Avorn
Arch Intern Med. 2005;165(12):1440.
EXTRACT | FULL TEXT  

Coxibs, Science, and the Public Trust
Daniel H. Solomon and Jerry Avorn
Arch Intern Med. 2005;165(2):158-160.
EXTRACT | FULL TEXT